CN Stock MarketDetailed Quotes

300573 Shenyang Xingqi Pharmaceutical

Watchlist
  • 86.75
  • -1.76-1.99%
Market Closed Oct 17 15:00 CST
15.13BMarket Cap47.04P/E (TTM)

Shenyang Xingqi Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
30.10%891.8M
22.10%349.88M
17.42%1.47B
10.02%1.1B
14.14%685.47M
-5.10%286.56M
21.59%1.25B
30.37%1B
29.89%600.57M
45.73%301.96M
Operating revenue
30.10%891.8M
22.10%349.88M
17.42%1.47B
10.02%1.1B
14.14%685.47M
-5.10%286.56M
21.59%1.25B
30.37%1B
29.89%600.57M
45.73%301.96M
Other operating revenue
-18.82%11.61M
----
20.08%27.86M
----
937.96%14.3M
----
544.94%23.2M
----
25.06%1.38M
----
Total operating cost
18.27%694.36M
19.36%313.25M
18.25%1.2B
18.50%899.95M
30.28%587.09M
22.57%262.44M
28.36%1.01B
31.01%759.48M
25.28%450.65M
28.65%214.11M
Operating cost
20.15%194.73M
21.42%83.61M
24.99%332.06M
24.11%247.7M
33.80%162.07M
15.22%68.86M
17.95%265.67M
20.12%199.58M
14.70%121.13M
25.19%59.77M
Operating tax surcharges
50.56%11.89M
52.81%4.06M
4.95%16.41M
2.85%12.56M
3.25%7.9M
-29.18%2.65M
13.32%15.64M
19.99%12.21M
21.42%7.65M
32.63%3.75M
Operating expense
21.93%331.38M
11.98%150.01M
15.51%535.31M
19.80%410.56M
34.49%271.78M
40.64%133.97M
37.00%463.43M
36.98%342.72M
31.70%202.09M
39.37%95.25M
Administration expense
10.62%78.69M
28.60%38.7M
17.08%154.49M
-6.68%112.53M
-3.05%71.14M
-13.97%30.09M
11.57%131.95M
40.42%120.59M
39.93%73.37M
36.24%34.98M
Financial expense
70.26%-1.04M
34.45%-1.19M
23.06%-6.23M
18.43%-4.95M
16.26%-3.51M
6.41%-1.82M
-231.94%-8.09M
-220.58%-6.07M
-214.38%-4.19M
-207.07%-1.95M
-Interest expense (Financial expense)
560.16%2.26M
284.14%605.37K
53.38%1.44M
1.21%815.91K
-43.35%342.7K
-66.48%157.59K
-84.35%937.47K
-82.76%806.19K
-81.86%604.89K
-71.18%470.18K
-Interest Income (Financial expense)
7.64%-3.65M
9.55%-1.85M
20.34%-7.91M
22.84%-5.92M
25.88%-3.95M
24.14%-2.04M
-1,096.03%-9.93M
-1,775.72%-7.68M
-3,757.49%-5.33M
-4,808.37%-2.69M
Research and development
1.28%78.7M
32.72%38.07M
14.89%167.3M
34.39%121.55M
53.58%77.71M
28.56%28.68M
64.64%145.61M
45.26%90.45M
32.20%50.6M
11.42%22.31M
Credit Impairment Loss
20.03%-3.58M
199.72%1.19M
-263.51%-3.73M
-11.89%-4.36M
-121.29%-4.47M
-279.72%-1.19M
-6,298.36%-1.03M
-112.82%-3.9M
-68.59%-2.02M
-142.68%-314.04K
Asset Impairment Loss
32.74%-1.74M
134.36%1.76M
-88.28%-8.29M
-5,545.02%-2.75M
-673.67%-2.58M
-849.64%-5.12M
-17.12%-4.41M
119.89%50.56K
-384.88%-333.79K
-9.06%-539.53K
Other net revenue
289.58%11.29M
949.02%10.63M
-42.65%8.3M
-11.51%6.9M
-11.54%2.9M
-1,207.11%-1.25M
35.90%14.47M
-16.27%7.8M
24,036.43%3.28M
-88.00%113.09K
Invest income
---24.24K
----
----
----
----
----
----
----
----
----
Asset deal income
589.43%154.62K
----
-108.92%-37.53K
-2,061.53%-31.59K
-2,061.53%-31.59K
----
-91.85%420.75K
-100.03%-1.46K
---1.46K
----
Other revenue
65.02%16.48M
51.66%7.68M
4.53%20.36M
20.59%14.05M
77.24%9.98M
423.87%5.06M
218.55%19.48M
229.65%11.65M
349.31%5.63M
37.89%966.65K
Operating profit
106.09%208.74M
106.63%47.25M
10.56%276.52M
-16.14%211.82M
-33.89%101.28M
-74.00%22.87M
0.69%250.1M
26.32%252.59M
49.27%153.2M
110.87%87.96M
Add:Non operating Income
-67.57%25.16K
----
-96.84%95.56K
-95.86%85.56K
15.26%77.56K
1,467.82%110.51K
-58.20%3.02M
8,323.83%2.07M
174.05%67.29K
--7.05K
Less:Non operating expense
1.67%8.44M
408.65%5.6M
-40.12%11.62M
-46.44%9.21M
-42.83%8.3M
-50.23%1.1M
60.54%19.41M
130.72%17.2M
296.28%14.52M
586.29%2.21M
Total profit
115.26%200.33M
90.40%41.66M
13.38%264.99M
-14.64%202.69M
-32.93%93.06M
-74.49%21.88M
-4.03%233.72M
23.34%237.46M
40.16%138.75M
107.19%85.76M
Less:Income tax cost
484.20%31M
173.19%6.91M
13.27%24.96M
-41.20%20.36M
-70.71%5.31M
-78.18%2.53M
-36.01%22.03M
48.76%34.63M
64.53%18.12M
201.25%11.59M
Net profit
92.95%169.32M
79.59%34.75M
13.39%240.04M
-10.11%182.33M
-27.25%87.75M
-73.91%19.35M
1.23%211.68M
19.84%202.84M
37.11%120.63M
97.55%74.17M
Net profit from continuing operation
92.95%169.32M
79.59%34.75M
13.39%240.04M
-10.11%182.33M
-27.25%87.75M
-73.91%19.35M
1.23%211.68M
19.84%202.84M
37.11%120.63M
97.55%74.17M
Net profit of parent company owners
92.95%169.32M
79.59%34.75M
13.39%240.04M
-10.11%182.33M
-27.25%87.75M
-73.91%19.35M
8.72%211.68M
29.96%202.84M
50.53%120.63M
123.36%74.17M
Earning per share
Basic earning per share
90.20%0.97
75.00%0.28
12.21%1.93
-10.37%1.47
-62.77%0.51
-80.95%0.16
-28.03%1.72
-13.68%1.64
38.38%1.37
110.00%0.84
Diluted earning per share
90.20%0.97
75.00%0.28
12.21%1.93
-10.37%1.47
-62.77%0.51
-80.95%0.16
-27.73%1.72
-13.68%1.64
38.38%1.37
110.00%0.84
Other composite income
Total composite income
92.95%169.32M
79.59%34.75M
13.39%240.04M
-10.11%182.33M
-27.25%87.75M
-73.91%19.35M
0.98%211.68M
19.84%202.84M
37.11%120.63M
97.55%74.17M
Total composite income of parent company owners
92.95%169.32M
79.59%34.75M
13.39%240.04M
-10.11%182.33M
-27.25%87.75M
-73.91%19.35M
8.43%211.68M
29.96%202.84M
50.53%120.63M
123.36%74.17M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 30.10%891.8M22.10%349.88M17.42%1.47B10.02%1.1B14.14%685.47M-5.10%286.56M21.59%1.25B30.37%1B29.89%600.57M45.73%301.96M
Operating revenue 30.10%891.8M22.10%349.88M17.42%1.47B10.02%1.1B14.14%685.47M-5.10%286.56M21.59%1.25B30.37%1B29.89%600.57M45.73%301.96M
Other operating revenue -18.82%11.61M----20.08%27.86M----937.96%14.3M----544.94%23.2M----25.06%1.38M----
Total operating cost 18.27%694.36M19.36%313.25M18.25%1.2B18.50%899.95M30.28%587.09M22.57%262.44M28.36%1.01B31.01%759.48M25.28%450.65M28.65%214.11M
Operating cost 20.15%194.73M21.42%83.61M24.99%332.06M24.11%247.7M33.80%162.07M15.22%68.86M17.95%265.67M20.12%199.58M14.70%121.13M25.19%59.77M
Operating tax surcharges 50.56%11.89M52.81%4.06M4.95%16.41M2.85%12.56M3.25%7.9M-29.18%2.65M13.32%15.64M19.99%12.21M21.42%7.65M32.63%3.75M
Operating expense 21.93%331.38M11.98%150.01M15.51%535.31M19.80%410.56M34.49%271.78M40.64%133.97M37.00%463.43M36.98%342.72M31.70%202.09M39.37%95.25M
Administration expense 10.62%78.69M28.60%38.7M17.08%154.49M-6.68%112.53M-3.05%71.14M-13.97%30.09M11.57%131.95M40.42%120.59M39.93%73.37M36.24%34.98M
Financial expense 70.26%-1.04M34.45%-1.19M23.06%-6.23M18.43%-4.95M16.26%-3.51M6.41%-1.82M-231.94%-8.09M-220.58%-6.07M-214.38%-4.19M-207.07%-1.95M
-Interest expense (Financial expense) 560.16%2.26M284.14%605.37K53.38%1.44M1.21%815.91K-43.35%342.7K-66.48%157.59K-84.35%937.47K-82.76%806.19K-81.86%604.89K-71.18%470.18K
-Interest Income (Financial expense) 7.64%-3.65M9.55%-1.85M20.34%-7.91M22.84%-5.92M25.88%-3.95M24.14%-2.04M-1,096.03%-9.93M-1,775.72%-7.68M-3,757.49%-5.33M-4,808.37%-2.69M
Research and development 1.28%78.7M32.72%38.07M14.89%167.3M34.39%121.55M53.58%77.71M28.56%28.68M64.64%145.61M45.26%90.45M32.20%50.6M11.42%22.31M
Credit Impairment Loss 20.03%-3.58M199.72%1.19M-263.51%-3.73M-11.89%-4.36M-121.29%-4.47M-279.72%-1.19M-6,298.36%-1.03M-112.82%-3.9M-68.59%-2.02M-142.68%-314.04K
Asset Impairment Loss 32.74%-1.74M134.36%1.76M-88.28%-8.29M-5,545.02%-2.75M-673.67%-2.58M-849.64%-5.12M-17.12%-4.41M119.89%50.56K-384.88%-333.79K-9.06%-539.53K
Other net revenue 289.58%11.29M949.02%10.63M-42.65%8.3M-11.51%6.9M-11.54%2.9M-1,207.11%-1.25M35.90%14.47M-16.27%7.8M24,036.43%3.28M-88.00%113.09K
Invest income ---24.24K------------------------------------
Asset deal income 589.43%154.62K-----108.92%-37.53K-2,061.53%-31.59K-2,061.53%-31.59K-----91.85%420.75K-100.03%-1.46K---1.46K----
Other revenue 65.02%16.48M51.66%7.68M4.53%20.36M20.59%14.05M77.24%9.98M423.87%5.06M218.55%19.48M229.65%11.65M349.31%5.63M37.89%966.65K
Operating profit 106.09%208.74M106.63%47.25M10.56%276.52M-16.14%211.82M-33.89%101.28M-74.00%22.87M0.69%250.1M26.32%252.59M49.27%153.2M110.87%87.96M
Add:Non operating Income -67.57%25.16K-----96.84%95.56K-95.86%85.56K15.26%77.56K1,467.82%110.51K-58.20%3.02M8,323.83%2.07M174.05%67.29K--7.05K
Less:Non operating expense 1.67%8.44M408.65%5.6M-40.12%11.62M-46.44%9.21M-42.83%8.3M-50.23%1.1M60.54%19.41M130.72%17.2M296.28%14.52M586.29%2.21M
Total profit 115.26%200.33M90.40%41.66M13.38%264.99M-14.64%202.69M-32.93%93.06M-74.49%21.88M-4.03%233.72M23.34%237.46M40.16%138.75M107.19%85.76M
Less:Income tax cost 484.20%31M173.19%6.91M13.27%24.96M-41.20%20.36M-70.71%5.31M-78.18%2.53M-36.01%22.03M48.76%34.63M64.53%18.12M201.25%11.59M
Net profit 92.95%169.32M79.59%34.75M13.39%240.04M-10.11%182.33M-27.25%87.75M-73.91%19.35M1.23%211.68M19.84%202.84M37.11%120.63M97.55%74.17M
Net profit from continuing operation 92.95%169.32M79.59%34.75M13.39%240.04M-10.11%182.33M-27.25%87.75M-73.91%19.35M1.23%211.68M19.84%202.84M37.11%120.63M97.55%74.17M
Net profit of parent company owners 92.95%169.32M79.59%34.75M13.39%240.04M-10.11%182.33M-27.25%87.75M-73.91%19.35M8.72%211.68M29.96%202.84M50.53%120.63M123.36%74.17M
Earning per share
Basic earning per share 90.20%0.9775.00%0.2812.21%1.93-10.37%1.47-62.77%0.51-80.95%0.16-28.03%1.72-13.68%1.6438.38%1.37110.00%0.84
Diluted earning per share 90.20%0.9775.00%0.2812.21%1.93-10.37%1.47-62.77%0.51-80.95%0.16-27.73%1.72-13.68%1.6438.38%1.37110.00%0.84
Other composite income
Total composite income 92.95%169.32M79.59%34.75M13.39%240.04M-10.11%182.33M-27.25%87.75M-73.91%19.35M0.98%211.68M19.84%202.84M37.11%120.63M97.55%74.17M
Total composite income of parent company owners 92.95%169.32M79.59%34.75M13.39%240.04M-10.11%182.33M-27.25%87.75M-73.91%19.35M8.43%211.68M29.96%202.84M50.53%120.63M123.36%74.17M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data